Leadership
Built by Experts in Rare Disease, Healthcare, Data & Technology
RDDT brings together leadership in biopharmaceutical commercialization, healthcare operations, clinical medicine, data science, and healthcare technology. Solving the rare disease diagnostic challenge requires more than an algorithm. It requires experience navigating medical decision-making, data governance, and sustainable organizational economics.
Experience. Purpose. Commitment.
RDDT provides U.S. healthcare organizations with Rare Disease Patient Analytic Services, which combine compliant patient-first funding, proprietary analytics, independent clinical review, and patient-consented, physician-directed evaluation to create new, sustainable revenue for healthcare organizations while advancing earlier recognition and diagnosis of previously unsuspected rare disease patients for whom potentially life-saving FDA-approved therapies already exist, within their existing healthcare systems.
Founders
On a Mission to Shorten the Rare Disease Diagnostic Journey
David Silas Connor
Founder & Chief Executive Officer
David brings more than 25 years of biopharmaceutical commercialization experience, with a career concentrated in rare and ultra-rare diseases. His experience includes eight ultra-rare disease therapy launches and leadership in emerging biotechnology commercialization. His career includes roles with Schering-Plough, RPR, Merck, ViroPharma, Shire Human Genetics, and Novartis, spanning oncology, hematology, genetics, rare disease, cardiovascular intervention, and neurology. David developed a perspective about healthcare and the gap between therapeutic innovation and the patients who remain undiagnosed. He recognized that healthcare's finite organizational capacity often prevents physicians from systematically pursuing rare disease suspicions, even when evidence is already present. His understanding of pharmaceutical compliance & commercialization, healthcare economics, and finite organizational capacity helped shape RDDT's independent clinical and economic operating architecture. David earned a Bachelor of Science in Business Marketing from Florida State University.
LinkedInKerry Hart
Founder & Chief Operating Officer
Kerry brings more than 30 years of healthcare executive leadership, complemented by his personal experience as an AL amyloidosis survivor. His career spans managed care, healthcare systems, physician practices, operational improvement, and executive leadership. Kerry previously founded and led a healthcare interim management and operations improvement company and served as CEO of a $300 million national case management and physician peer-review organization. He also served as a National Practice Leader for Arthur Andersen Business Consulting and led Aetna Health Plan's Southeast Region Managed Care Operations. Kerry holds a master's degree in Management and Organizational Behavior from Western Kentucky University, where he also earned undergraduate degrees in Agribusiness and Journalism. His combination of personal experience and operational expertise provides an important connection between RDDT's mission and the practical realities of healthcare delivery.
LinkedInLeadership Team
Built Specifically for the Challenge
Mark Tumblin
Chief Technology Officer
Mark brings approximately 35 years of experience in healthcare information technology, clinical data systems, analytics, and technology leadership. His background includes senior leadership roles across major healthcare and technology organizations, with experience in advanced analytics, population health, regulatory reporting, and healthcare data infrastructure. At RDDT, Mark leads the advancement of proprietary analytical methodologies and the secure technology architecture supporting health-system partnerships.
LinkedInMike Fitzgerald
Senior Vice President, Business Development
Mike brings more than 25 years of healthcare leadership experience across business development, strategic partnerships, healthcare technology, clinical innovation, and operational strategy. His career includes leadership and consulting roles with health systems, advancing telehealth, remote patient monitoring, Epic Community Connect, patient engagement, and other healthcare technology initiatives. Working across clinical, technical, legal, and operational disciplines, he helps translate complex requirements into practical approaches that support responsible collaboration and earlier recognition of invisible patients awaiting diagnosis.
LinkedInJeff Seraphine
Executive Vice President, Provider Partnerships
Jeff brings more than 30 years of hospital and health-system leadership experience, from managing individual hospitals to overseeing multi-state hospital groups. His career spans rural and urban markets, including critical access hospitals and 500-bed regional referral centers. At LifePoint Health, Jeff helped grow a small rural hospital company into a Fortune 500 health system. As President of the Eastern Group, he oversaw 25 hospitals generating $2.5 billion in annual net revenue across four states. He was the inaugural President of the Duke LifePoint Partnership. Jeff is a past Chairman of the Kentucky Hospital Association and holds a Master's in Health Administration from the University of Kentucky.
LinkedInDianne Miller
Vice President, Operations
Dianne brings experience in healthcare operations, client solutions, contracting, compliance, physician practice optimization, and organizational improvement. Her background includes work with physician practice organizations, healthcare startups, and health systems. She holds professional credentials in healthcare compliance, human resources, and Lean Six Sigma.
LinkedInDr. David Slosky
Acting Chief Medical Officer
Dr. Slosky serves RDDT in a fractional, consultative clinical leadership role. A board-certified cardiologist with more than 40 years of medical experience, he has maintained an active clinical practice and previously served as an Assistant Professor of Medicine at Vanderbilt University Medical Center. His experience supports RDDT's commitment to independent clinical expertise, physician authority, and responsible medical evaluation.
LinkedInDr. Rhys Williams
Chief Data Science Officer
Dr. Williams brings extensive experience in epidemiology, statistics, health economics, and outcomes research. His career has included senior research and analytics positions in the biopharmaceutical and healthcare sectors. He holds a doctorate in Epidemiology from Boston University and has authored more than 40 peer-reviewed scientific publications. His expertise reinforces the scientific and analytical foundations of RDDT's disease-specific methodologies.
LinkedInBoard Members & Advisors
Guided by Experience Across the Rare Disease Ecosystem.
Our board members and advisors bring experience in community-based care, healthcare leadership, biopharmaceutical commercialization, finance, and governance.
Dr. Jeff Patton
Investor and Advisor
Dr. Patton is a board-certified hematologist-oncologist and longtime leader in community oncology. He has held senior leadership roles at Tennessee Oncology and OneOncology, bringing practical experience in physician-led specialty care.
LinkedInMark Smith
Investor and Board Member
Mark is an owner, Secretary/Treasurer, and Chief Compliance Officer of Lee, Danner, and Bass, Inc. A Certified Public Accountant, he contributes experience in financial management, accounting, and governance.
LinkedInBrock F. Weathers
Advisor
Brock brings more than 28 years of healthcare and biopharmaceutical experience, including nine product launches, primarily first-in-class biologics. His work spans health-system relationships, specialty products, and rare disease commercialization.
LinkedInJoin the Mission
RDDT is building the team and the partnerships that will define the next chapter of rare disease patient care.
If you bring expertise in rare disease, clinical analytics, healthcare operations, biopharma strategy, or data governance — and you share the conviction that the diagnostic gap in rare disease is a solvable problem — we want to hear from you.
Contact Us